Company
Vedanta Biosciences
Writing the next chapter in GI health
Also known as Vedanta Biosciences, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Cambridge, Massachusetts, United States
- Legal name
- Vedanta Biosciences, Inc.
- vedantabio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Vedanta is advancing first-in-class Live Biotherapeutic Products (LBP) to treat serious gastrointestinal diseases using defined consortia of bacteria.
Funding snapshot
- Total raised
- $240MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $60M2026-08-06
Funding rounds
- Round, 2026
- $60M2026-08-06, Company stated
- Grant
- $3.9M2024-04-30, Company stated
- Round, 2023
- $118M2023-03-01, SEC form D sold, 25 investors
- Round, 2021
- $68.4M2021-07-16, SEC form D sold, 18 investors
- Round, 2019
- $8M2019-09-11, SEC form D sold, 4 investors
- Round, 2018
- $45.4M2018-12-21, SEC form D sold, 13 investors
Loading relationship preview